• COMPETITION ROUNDTABLE What’s ahead in a changing landscape for pharma? Pharm Exec meets with key Big Pharma and biotech executives responsible for company competitive intelligence activities for a wide-ranging discussion highlighting current environmental trends and future challenges and opportunities under a changing business model. By William Looney, Editor-in-Chief

• COMPANY PROFILE: GILEAD—TRANSITIONING FOR DIVERSITY
Senior Editor Walter Armstrong profiles Gilead Sciences and its strategy for growth, building on the fast-moving HIV segment to drive a more diversified product portfolio.

• PATIENT COMPLIANCE
News & Online Editor George Koroneos reports on the latest tools, tactics, and trends to reach pharma’s largest untapped revenue stream—non-compliant and non-adherent patients.

• LEVERAGING THE POTENTIAL OF PHARMERGING MARKETS
This IMS-authored feature showcases the practical strategies for taking pharma the next step in crucial growth markets

• AGENCY INSIGHT
Johanna Skilling of Saatchi & Saatchi Wellness discusses an innovative campaign that helped one client’s sales go from zero to 60 in no time flat. A unique combination of e-marketing, DTC, and professional marketing turned out to be the prescription for success.

• E-MARKETING
Lynn O’Connor Vos, CEO of Grey Healthcare Group, maintains that pharma companies should make a stronger push for mobile marketing and compliance techniques, rather than purely focusing on the Internet as the new advertising/compliance medium. The technology is there. Now, how do you harness it?

Bonus Distribution:
CBI: 4th Tracking State Laws and Aggregate Spend